Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass targeting TGF-β2. It holds potential as an anti-scarring agent in glaucoma research [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass targeting TGF-β2. It holds potential as an anti-scarring agent in glaucoma research [1] [2]. |
Molecular Weight | N/A |
CAS No. | 285985-06-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lerdelimumab 285985-06-0 inhibitor inhibit